ArticleCurrent oncology (Toronto, Ont.)2023

Seven-Year Single-Center Experience of the Efficacy and Safety of Ferric Carboxymaltose in Cancer Patients with Iron-Deficiency Anemia.

Burak Yasin Aktaş et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.